Side-by-side comparison of AI visibility scores, market position, and capabilities
Eucalyptus is Australia's largest digital health company with US$450M+ ARR and triple-digit quarterly growth; operates Juniper, Pilot, Software, and Kin clinics; agreed acquisition by Hims & Hers for up to $1.15B in 2026.
Eucalyptus is an Australian digital health company founded in 2019 by Tim Doyle, Benny Kleist, Alexey Mitko, and Charlie Gearside. The company operates a portfolio of specialized telehealth brands spanning key consumer health categories: Juniper (women''s weight management and menopause), Pilot (men''s health including hair loss and erectile dysfunction), Software (dermatology and skincare), and Kin (reproductive health and fertility). Each brand operates as a distinct consumer-facing clinic with its own branding, medical teams, and care protocols, while sharing Eucalyptus''s underlying technology, regulatory, and clinical infrastructure.
Revvity (RVTY) reported ~$2.9B revenue in FY2024. Life science tools and diagnostics company providing instruments, reagents, and software for genomics, newborn screening, and drug discovery. HQ: Waltham, MA.
Revvity, Inc. (formerly PerkinElmer) is a global life science tools and diagnostics company, rebranded in 2023 to signal its transformation from a diversified instruments company into a focused provider of solutions for reproductive health, genomics, and applied markets. The company operates in two segments: Life Sciences (analytical instruments, reagents, software for pharmaceutical and academic research) and Diagnostics (immunoassay and molecular diagnostic systems for clinical and screening applications). Revvity is the global leader in newborn screening, processing the tests that check newborns for metabolic and genetic disorders shortly after birth.
Monitor how your brand performs across ChatGPT, Gemini, Perplexity, Claude, and Grok daily.